Subtype
Malignant Neck Neoplasm
CI-CAN-00001148Explore in graph →
607 active trials11 approved drugs67 evidence items
- NCIt
- C4940
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001148Explore in graph →
Clinical trials
2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02839655 | Prospective Study Assessing Thyroidectomy Using Robot(EVATAR) | unknown | Phase 2 | 17 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 15, 2018 | clinicaltrials |
| NCT02552550 | Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx | terminated | — | 12 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jun 4, 2018 |
| clinicaltrials |
| NCT02035527 | Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 | 3 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 24, 2018 | clinicaltrials |
| NCT02465424 | Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients(QaLM) | completed | — | 173 | Velindre NHS TrustOTHER_GOV | 1 | May 22, 2018 | clinicaltrials |
| NCT03529279 | CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy | unknown | Phase 3 | 1,324 | Sun Yat-sen UniversityOTHER | 0 | May 18, 2018 | clinicaltrials |
| NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 440 | Wei JiangOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03130270 | Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 29 | Guilin Medical University, ChinaOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC(NX-NPC) | unknown | Phase 3 | 632 | Sun Yat-sen UniversityOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT00098345 | Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer | completed | Phase 2 | 40 | Genzyme, a Sanofi CompanyINDUSTRY | 2 | May 7, 2018 | clinicaltrials |
| NCT03514251 | Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery | unknown | N/A | 400 | Bo Wang,MDOTHER | 1 | May 2, 2018 | clinicaltrials |
| NCT03510143 | Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery | unknown | N/A | 330 | Seoul National University HospitalOTHER | 1 | Apr 27, 2018 | clinicaltrials |
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | unknown | Phase 1 | 49 | National Cancer Centre, SingaporeOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01872962 | Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 480 | Sun Yat-sen UniversityOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01462474 | Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma(FMTN-I-LNPC) | completed | Phase 1 | 20 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03500666 | Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection | unknown | N/A | 10 | Fujian Medical UniversityOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01534585 | Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma | completed | Phase 1 / Phase 2 | 48 | Taizhou HospitalOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)(DeCIDE) | completed | Phase 3 | 285 | University of ChicagoOTHER | 5 | Apr 9, 2018 | clinicaltrials |
| NCT01424878 | Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients | completed | — | 150 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01811212 | Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2018 | clinicaltrials |
| NCT02776124 | Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients | completed | Phase 2 | 60 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT03469544 | Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer | unknown | — | 90 | Assiut UniversityOTHER | 0 | Mar 19, 2018 | clinicaltrials |
| NCT00462735 | Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer | completed | Phase 2 | 33 | Johnny KaoOTHER | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01585428 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | completed | Phase 2 | 29 | National Cancer Institute (NCI)NIH | 1 | Mar 7, 2018 | clinicaltrials |
| NCT01316757 | Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer | completed | Phase 2 | 24 | Fox Chase Cancer CenterOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03427359 | Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma | completed | Phase 2 | 65 | The University of Hong Kong-Shenzhen HospitalOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT03202173 | The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy | unknown | N/A | 31 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00408694 | Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 2 | Jan 30, 2018 | clinicaltrials |
| NCT03411954 | Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients | unknown | — | 100 | Zhejiang Cancer HospitalOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT00126568 | Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer | terminated | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jan 19, 2018 | clinicaltrials |
| NCT03398980 | Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy | completed | — | 94 | Yuan-hong GaoOTHER | 0 | Jan 16, 2018 | clinicaltrials |
| NCT02628912 | Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Jan 4, 2018 | clinicaltrials |
| NCT03387943 | PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma | unknown | Phase 2 | 30 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Jan 3, 2018 | clinicaltrials |
| NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | unknown | Phase 2 | 328 | Yun-fei XiaOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03344068 | Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 408 | Sun Yat-sen UniversityOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT02225496 | Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 15, 2017 | clinicaltrials |
| NCT03367884 | Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer | not yet recruiting | N/A | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT02584790 | NBI to Detect Post-RT Mucosal Residual NPC | completed | N/A | 55 | Pamela Youde Nethersole Eastern HospitalOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT03363347 | BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer | completed | — | 25 | Heidelberg UniversityOTHER | 0 | Dec 6, 2017 | clinicaltrials |
| NCT02022293 | Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis | suspended | Phase 2 | 324 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 4, 2017 | clinicaltrials |
| NCT03359668 | CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer | completed | N/A | 47 | University Health Network, TorontoOTHER | 0 | Dec 2, 2017 | clinicaltrials |
| NCT03357107 | Local Control After Robot-assisted Supraglottic Laryngectomy | completed | — | 122 | Hospices Civils de LyonOTHER | 1 | Nov 30, 2017 | clinicaltrials |
| NCT03045484 | Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy | unknown | N/A | 70 | Sun Yat-sen UniversityOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT02298595 | Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma | withdrawn | Phase 1 / Phase 2 | 0 | Julie E. Bauman, MD, MPHOTHER | 0 | Nov 13, 2017 | clinicaltrials |
| NCT03290001 | The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients | unknown | — | 1,000 | Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT01435252 | A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab | completed | Phase 2 | 68 | University of ZurichOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 2 | 184 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT03314051 | Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA | completed | — | 366 | Taichung Veterans General HospitalOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT02758158 | Tri-modal Imaging Instrument for Thyroid Cancer | completed | N/A | 9 | University Health Network, TorontoOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT02068157 | Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer | terminated | Phase 2 | 3 | Roswell Park Cancer InstituteOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT00965003 | MRI Laryngeal Imaging With a Surface Coil | terminated | Early Phase 1 | 3 | Stanford UniversityOTHER | 1 | Oct 5, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jun 15, 2018source: clinicaltrials